• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Prevalence of Substandard and Falsified Essential Medicines: Still an Incomplete Picture.

作者信息

Mackey Tim K

机构信息

Division of Infectious Diseases and Global Public Health, Department of Anesthesiology, School of Medicine, University of California, San Diego.

Global Health Policy Institute, San Diego, California.

出版信息

JAMA Netw Open. 2018 Aug 3;1(4):e181685. doi: 10.1001/jamanetworkopen.2018.1685.

DOI:10.1001/jamanetworkopen.2018.1685
PMID:30646099
Abstract
摘要

相似文献

1
Prevalence of Substandard and Falsified Essential Medicines: Still an Incomplete Picture.不合格和伪造基本药物的流行情况：仍不全面。
JAMA Netw Open. 2018 Aug 3;1(4):e181685. doi: 10.1001/jamanetworkopen.2018.1685.
2
A cross-sectional analysis of falsified, counterfeit and substandard medicines in a low-middle income country.在一个中低收入国家进行的假冒伪劣药品的横断面分析。
BMC Public Health. 2020 May 20;20(1):743. doi: 10.1186/s12889-020-08897-x.
3
Prevalence and Estimated Economic Burden of Substandard and Falsified Medicines in Low- and Middle-Income Countries: A Systematic Review and Meta-analysis.中低收入国家不合格和假冒药品的流行情况及经济负担估计：系统评价和荟萃分析。
JAMA Netw Open. 2018 Aug 3;1(4):e181662. doi: 10.1001/jamanetworkopen.2018.1662.
4
Surveillance for falsified and substandard medicines in Africa and Asia by local organizations using the low-cost GPHF Minilab.非洲和亚洲的地方组织使用低成本的全球公共卫生实验室微量实验室对假药和劣药进行监测。
PLoS One. 2017 Sep 6;12(9):e0184165. doi: 10.1371/journal.pone.0184165. eCollection 2017.
5
Substandard and Falsified Medicines: Proposed Methods for Case Finding and Sentinel Surveillance.伪劣药品：案例发现和哨点监测的建议方法。
JMIR Public Health Surveill. 2021 Aug 16;7(8):e29309. doi: 10.2196/29309.
6
Substandard and Falsified Antibiotics and Medicines against Noncommunicable Diseases in Western Cameroon and Northeastern Democratic Republic of Congo.喀麦隆西部和刚果民主共和国东北部的非传染性疾病用劣药和假药
Am J Trop Med Hyg. 2020 Aug;103(2):894-908. doi: 10.4269/ajtmh.20-0184. Epub 2020 May 7.
7
Characterizing Medicine Quality by Active Pharmaceutical Ingredient Levels: A Systematic Review and Meta-Analysis across Low- and Middle-Income Countries.基于活性药物成分水平评估药品质量：一项在中低收入国家开展的系统评价和荟萃分析。
Am J Trop Med Hyg. 2022 Jun 15;106(6):1778-1790. doi: 10.4269/ajtmh.21-1123.
8
Economic cost of substandard and falsified human medicines and cosmetics with banned ingredients in Tanzania from 2005 to 2015: a retrospective review of data from the regulatory authority.2005 年至 2015 年坦桑尼亚不合规和假冒伪劣人用药品及含禁用成分化妆品的经济成本：监管机构数据的回顾性分析。
BMJ Open. 2018 Jun 27;8(6):e021825. doi: 10.1136/bmjopen-2018-021825.
9
Modeling the Health and Economic Impact of Substandard and Falsified Medicines: A Review of Existing Models and Approaches.模拟劣药和假药的健康和经济影响：对现有模型和方法的综述。
Am J Trop Med Hyg. 2022 Jul 13;107(1):14-20. doi: 10.4269/ajtmh.21-1133.
10
Prevalence of Substandard Amoxicillin Oral Dosage Forms in the National Capital District of Papua New Guinea.巴布亚新几内亚首都地区劣质阿莫西林口服剂型的流行情况。
Am J Trop Med Hyg. 2021 May 17;105(1):238-244. doi: 10.4269/ajtmh.20-1570.

引用本文的文献

1
Medicine quality assessment in Nepal using semi randomised sampling and evaluation of a small scale dissolution test and portable Raman spectrometers.在尼泊尔使用半随机抽样以及对小规模溶出度试验和便携式拉曼光谱仪进行评估的药品质量评估
Sci Rep. 2025 Aug 21;15(1):30746. doi: 10.1038/s41598-025-16340-7.
2
Suspected poor-quality medicines in Kenya: a retrospective descriptive study of medicine quality-related complaints reports in Kenya's pharmacovigilance database.肯尼亚疑似劣质药品：肯尼亚药物警戒数据库中与药品质量相关投诉报告的回顾性描述性研究。
BMC Public Health. 2024 Sep 19;24(1):2561. doi: 10.1186/s12889-024-20036-4.
3
Circulation of COVID-19-Related Medicines on Japanese Websites during the COVID-19 Pandemic and Their Quality and Authenticity.
新冠疫情期间日本网站上新冠相关药品的流通及其质量和真实性。
Am J Trop Med Hyg. 2024 Sep 17;111(5):1097-1106. doi: 10.4269/ajtmh.23-0710. Print 2024 Nov 6.
4
The impact of global falsified medicines regulation on healthcare stakeholders in the legitimate pharmaceutical supply chain: a systematic review.全球假药监管对合法药品供应链中医疗保健利益相关者的影响：一项系统综述。
Front Med (Lausanne). 2024 Jul 18;11:1429872. doi: 10.3389/fmed.2024.1429872. eCollection 2024.
5
Understanding, readiness, and response of healthcare professionals in combating falsified medical products in Eritrea: a population-based survey.厄立特里亚医疗保健专业人员在打击假冒医疗产品方面的理解、准备情况及应对措施：一项基于人群的调查
Ther Adv Drug Saf. 2023 Dec 15;14:20420986231213713. doi: 10.1177/20420986231213713. eCollection 2023.
6
The quality of antiretroviral medicines: an uncertain problem.抗逆转录病毒药物的质量：一个不确定的问题。
BMJ Glob Health. 2023 Mar;8(3). doi: 10.1136/bmjgh-2022-011423.
7
Recall of substandard medicines in Brazil during the period 2010-2018.2010-2018 年巴西召回不合格药品情况。
BMC Health Serv Res. 2023 Mar 10;23(1):238. doi: 10.1186/s12913-023-09225-w.
8
A critical review on the availability of substandard and falsified medicines online: Incidence, challenges and perspectives.关于网上不合标准和伪造药品可得性的批判性综述：发生率、挑战与展望。
J Med Access. 2022 Feb 15;6:23992026221074548. doi: 10.1177/23992026221074548. eCollection 2022 Jan-Dec.
9
Review of drug recalls and quality of pharmaceutical products in Nepal.尼泊尔药品召回和药品质量回顾。
BMJ Open. 2022 Jul 4;12(7):e053479. doi: 10.1136/bmjopen-2021-053479.
10
The quality of medical products for cardiovascular diseases: a gap in global cardiac care.心血管疾病医疗产品的质量：全球心脏护理中的差距。
BMJ Glob Health. 2021 Sep;6(9). doi: 10.1136/bmjgh-2021-006523.